Investors that are looking for some new shares to buy in January may want to look at the ones listed below.
These three ASX shares may be from very different areas of the market but one thing they have in common is that they have been tipped to climb higher from here. They are as follows:
Aristocrat Leisure Limited (ASX: ALL)
The first ASX share to look at is Aristocrat Leisure. It is one of the world's leading gaming technology companies. Aristocrat has a portfolio of world class pokie machines and a growing digital business which has become a significant contributor to its earnings in recent years. That latter is being driven by the increasing popularity of games such as Raid. The company is also in the process of acquiring London-listed leading global online gambling software and content supplier, Playtech, for $5 billion. All in all, this has analysts tipping Aristocrat to continue its strong growth in the coming years.
Morgans is positive on the company. It currently has an add rating and $52.00 price target on its shares.
Goodman Group (ASX: GMG)
Another ASX share that could be in the buy zone is Goodman. It is a global integrated commercial and industrial property company with operations throughout Australia, New Zealand, Asia, Europe, the United Kingdom, North America and Brazil. Goodman has a world class portfolio of properties which have exposure to key growth markets such as ecommerce and logistics. Thanks to strong demand for these properties, Goodman has been growing at a rapid rate over the last decade and has been tipped to continue doing so in the future.
Citi is very positive on Goodman. Its analysts currently have a buy rating and $27.50 price target on its shares.
Nanosonics Ltd (ASX: NAN)
A final ASX share to look at is Nanosonics. It is one of the world's leading infection prevention companies. At present, Nanosonics is best known for its industry-leading trophon EPR disinfection system for ultrasound probes. However, management is in the process of expanding its portfolio with several new products. One of these is the Nanosonics Coris platform. This new platform, which is expected to be launched in calendar year 2023, is for cleaning flexible endoscopes. This could be an even bigger market than ultrasound probe disinfection.
Morgans is also bullish on Nanosonics. Its analysts have an add rating and $6.97 price target on its shares.
